In the areas with tumor fields infiltrated by immune cells (CD45+/S100+ ROIs) melanomas with brain metastases (BM) showed lower expression of VISTA and IDO1 and no overexpression of genes when compared to tumors without metastases (NM) (Table 3, Figures 4b, e, f). This evidence concerns the gene IDO1 and neoplasm.